Benzinga - Tue, 04 May 2021 05:00:39 -0400
Benzinga - Mon, 03 May 2021 12:00:39 -0400
Benzinga - Thu, 15 Apr 2021 08:55:06 -0400
Benzinga - Fri, 09 Apr 2021 07:03:00 -0400
load more
Sector: Health Care.Industry: Biotechnology
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HGENHumanigen-6.6%1B

Humanigen Company Questions & Answers

Q

How do I buy Humanigen (HGEN) stock?

A

You can purchase shares of Humanigen (NASDAQ: HGEN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Humanigen's (HGEN) main competitors?

Q

What is the target price for Humanigen?

A

The latest price target for Humanigen (NASDAQ: HGEN) was reported by HC Wainwright & Co. on 2021-04-12. The analyst firm set a price target for 36.00 expecting HGEN to rise to within 12 months (a possible 102.65% upside). 6 analyst firms have reported ratings in the last year.

Q

How much is Humanigen (HGEN) stock ?

A

The stock price for Humanigen (NASDAQ: HGEN) is $17.765 last updated Today at 3:10:51 PM.

Q

When is the next Humanigen (HGEN) dividend?

A

There are no upcoming dividends for Humanigen.

Q

When is Humanigen (NASDAQ:HGEN) reporting earnings?

A

There are no earnings for Humanigen

Q

When is the upcoming split for HGEN?

A

There is no upcoming split for Humanigen.